t ayers pelz (20 risultati)

paperback. Condizione: Good. The cover shows normal wear. Fast shipping and order satisfaction guaranteed. A portion of your purchase benefits Non-Profit Organizations, First Aid and Fire Stations!

Condizione: very_good. Book is in very good condition and may include minimal underlining highlighting. The book can also include "From the library of" labels. May not contain miscellaneous items toys, dvds, etc. . We offer 100% money back guarantee and 24 7 customer service.

Condizione: very_good. Book is in very good condition and may include minimal underlining highlighting. The book can also include "From the library of" labels. May not contain miscellaneous items toys, dvds, etc. . We offer 100% money back guarantee and 24 7 customer service.

paperback. Condizione: As New. Paperback--no flaws.

Condizione: As New. Unread book in perfect condition.

Condizione: New.

Paperback. Condizione: New.

Paperback. Condizione: New.

Condizione: New.

Paperback. Condizione: Used; Very Good. ***Simply Brit*** Welcome to our online used book store, where affordability meets great quality. Dive into a world of captivating reads without breaking the bank. We take pride in offering a wide selection of used books, from classics to hidden gems, ensuring there is something for every literary palate. All orders are shipped within 24 hours and our lightning fast-delivery within 48 hours coupled with our prompt customer service ensures a smooth journey from ordering to delivery. Discover the joy of reading with us, your trusted source for affordable books that do not compromise on quality.

Paperback. Condizione: new. Paperback. Immunology is the most crowded and most actively traded sub-sector in biopharma. Every major indication - rheumatoid arthritis, psoriasis, inflammatory bowel disease, atopic dermatitis - has four to eight approved drugs and a pipeline of challengers. The catalysts are not binary in the traditional sense. They are comparative. The question is never just whether the drug works. It is whether it works better than adalimumab, ustekinumab, dupilumab, or the class leader that set the bar last cycle. This volume applies the BTH framework to inflammatory and autoimmune drug development. The Inflammation Path Tool scores six nodes, antigen presentation, innate activation, adaptive response, inflammatory cascade, autoimmunity loop, and intervention point, to determine how much information a catalyst will actually deliver and what the outcome distribution looks like before the data is unblinded.The MoA Tool covers every mechanism class in the sub-sector: anti-TNF, anti-IL, JAK inhibitors, T cell costimulation blockade, B cell depletion, CAR-T in autoimmune, tolerogenic vaccines, and selective cytokine modulators. The Catalyst Stack maps twenty catalyst types, from Phase 1 through biosimilar entry and label expansion, with IV expansion and crush figures calibrated to the immunology timeline. The Trade Setup chapter delivers eight named structures built for the head-to-head trial environment, the AdCom, the PDUFA, and the long-cycle franchise catalyst. Immunology rewards the trader who understands the class, not just the drug. This book connects the Biology to the trade! In the series: Book 1: OncologyBook 2: Immunology & AutoimmuneBook 3: NeuroscienceBook 4: Rare Disease & Orphan Drugs Book 5: Cardiovascular Book 6: Metabolic Disease & Endocrinology Book 7: Gene Therapy & RNA Therapeutics Book 8: Infectious Disease & Vaccines This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

Condizione: New. Print on Demand.

Taschenbuch. Condizione: Neu. Neuware - >This volume applies the BTH framework to inflammatory and autoimmune drug development. The Inflammation Path Tool scores six nodes, antigen presentation, innate activation, adaptive response, inflammatory cascade, autoimmunity loop, and intervention point, to determine how much information a catalyst will actually deliver and what the outcome distribution looks like before the data is unblinded.The MoA Tool covers every mechanism class in the sub-sector: anti-TNF, anti-IL, JAK inhibitors, T cell costimulation blockade, B cell depletion, CAR-T in autoimmune, tolerogenic vaccines, and selective cytokine modulators. The Catalyst Stack maps twenty catalyst types, from Phase 1 through biosimilar entry and label expansion, with IV expansion and crush figures calibrated to the immunology timeline. The Trade Setup chapter delivers eight named structures built for the head-to-head trial environment, the AdCom, the PDUFA, and the long-cycle franchise catalyst. Immunology rewards the trader who understands the class, not just the drug. This book connects the Biology to the trade! >Book 1: OncologyBook 2: Immunology & AutoimmuneBook 3: NeuroscienceBook 4: Rare Disease & Orphan Drugs Book 5: Cardiovascular Book 6: Metabolic Disease & Endocrinology Book 7: Gene Therapy & RNA Therapeutics Book 8: Infectious Disease & Vaccines.

Condizione: As New. Unread book in perfect condition.

Paperback. Condizione: New.

PAP. Condizione: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

PAP. Condizione: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Paperback / softback. Condizione: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.

Paperback. Condizione: new. Paperback. Immunology is the most crowded and most actively traded sub-sector in biopharma. Every major indication - rheumatoid arthritis, psoriasis, inflammatory bowel disease, atopic dermatitis - has four to eight approved drugs and a pipeline of challengers. The catalysts are not binary in the traditional sense. They are comparative. The question is never just whether the drug works. It is whether it works better than adalimumab, ustekinumab, dupilumab, or the class leader that set the bar last cycle. This volume applies the BTH framework to inflammatory and autoimmune drug development. The Inflammation Path Tool scores six nodes, antigen presentation, innate activation, adaptive response, inflammatory cascade, autoimmunity loop, and intervention point, to determine how much information a catalyst will actually deliver and what the outcome distribution looks like before the data is unblinded.The MoA Tool covers every mechanism class in the sub-sector: anti-TNF, anti-IL, JAK inhibitors, T cell costimulation blockade, B cell depletion, CAR-T in autoimmune, tolerogenic vaccines, and selective cytokine modulators. The Catalyst Stack maps twenty catalyst types, from Phase 1 through biosimilar entry and label expansion, with IV expansion and crush figures calibrated to the immunology timeline. The Trade Setup chapter delivers eight named structures built for the head-to-head trial environment, the AdCom, the PDUFA, and the long-cycle franchise catalyst. Immunology rewards the trader who understands the class, not just the drug. This book connects the Biology to the trade! In the series: Book 1: OncologyBook 2: Immunology & AutoimmuneBook 3: NeuroscienceBook 4: Rare Disease & Orphan Drugs Book 5: Cardiovascular Book 6: Metabolic Disease & Endocrinology Book 7: Gene Therapy & RNA Therapeutics Book 8: Infectious Disease & Vaccines This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.

Paperback. Condizione: new. Paperback. Small cap biotech companies spend hundreds of millions of dollars and over ten years moving experimental drug candidates from concept to fully approved drugs. For late stage drug candidates, those in Phase III, positive or negative data can result in either massive gains or devastating declines in the sponsoring company's stock price. This "ultimate catalyst event" provides smart, organized & nimble option traders spectacular & consistent trading opportunities. In this unique book, the author provides individuals unfamiliar with the world of small cap biotech a fast, simplified and efficient approach to identify, analyze & execute trading strategies using options. The following topics, amongst others, are covered in this book: * Description of the FDA drug trial process, from pre-clinical to Phase III & beyond * Identification, categorization & organization of small cap biotech companies * Structured & streamlined approach to assess small cap biotech companies * Notes on trading strategy & tactics * Detailed description of option trading structures best suited for small cap biotech This book is an absolute "must have" for individuals thinking about trading in the fast paced and often confusing world of small cap biotech. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.